Leaflet SEREVENT CFC-FREE INHALER 25mcg 25mcg / dose pressurised inhalation suspension
Indicated for: asthma; chronic obstructive pulmonary disease
Route of administration: inhalation
Substance: salmeterol (beta-2 adrenergic agonist)
ATC: R03AC12 (Respiratory system | Adrenergics, inhalants | Selective beta-2-adrenoreceptor agonists)
This medicine may increase blood sugar.
This medicine may increase the risk of heart rhythm disturbances.
Salmeterol is a long-acting beta-2 adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD). It works by relaxing the smooth muscles of the airways, improving airflow and preventing respiratory symptoms such as shortness of breath and wheezing.
Salmeterol is administered via inhalation, usually twice daily, and is indicated for patients requiring maintenance therapy to control respiratory symptoms. It is often used in combination with inhaled corticosteroids to reduce inflammation and prevent exacerbations.
Common side effects include tremors, palpitations, headache, and throat irritation. In rare cases, severe adverse reactions such as paradoxical bronchospasm or cardiac arrhythmias may occur. It is important for patients to use salmeterol as directed by their healthcare provider to avoid overdose or misuse.
Salmeterol is a valuable therapeutic option for patients with chronic respiratory conditions, helping to improve quality of life and prevent debilitating symptoms.
General data about SEREVENT CFC-FREE INHALER 25mcg 25mcg / dose
- Substance: salmeterol
- Date of latest medicines list: 01-07-2013
- Product code: W42677001
- Concentration: 25mcg / dose
- Pharmaceutical form: pressurised inhalation suspension
- Quantity: 1
- Product type: Original
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.